Literature DB >> 2244771

Muscle involvement in the scleroderma syndromes.

R A Ringel1, J E Brick, J F Brick, L Gutmann, J E Riggs.   

Abstract

Muscle involvement was identified in 14 patients with scleroderma or a connective tissue disease overlap syndrome with predominant features of scleroderma. Patients presented with symmetrical proximal weakness indistinguishable from other inflammatory myopathies. Creatine kinase and electromyography were useful to demonstrate muscle involvement. Muscle histopathology demonstrated primarily the vasculopathy of scleroderma or polymyositis in similar numbers of patients. Scleroderma vasculopathy and polymyositis generally occur without specificity to diffuse scleroderma, the calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia syndrome, or an overlap syndrome with arthritis. Polymyositis also occurs when the vasculopathy of scleroderma involves other organ systems.

Entities:  

Mesh:

Year:  1990        PMID: 2244771

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.

Authors:  Julie J Paik; Fredrick M Wigley; Thomas E Lloyd; Andrea M Corse; Livia Casciola-Rosen; Ami A Shah; Francesco Boin; Laura K Hummers; Andrew L Mammen
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

2.  The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus.

Authors:  John D Pauling; Sarah Skeoch; Julie J Paik
Journal:  Indian J Rheumatol       Date:  2021-01-18

Review 3.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

Review 4.  Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Authors:  Ulrich A Walker; Philip J Clements; Yannick Allanore; Oliver Distler; Chester V Oddis; Dinesh Khanna; Daniel E Furst
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

Review 5.  Pediatric scleroderma: systemic or localized forms.

Authors:  Kathryn S Torok
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

6.  Impaired skeletal muscle microcirculation in systemic sclerosis.

Authors:  Sasan Partovi; Anja-Carina Schulte; Markus Aschwanden; Daniel Staub; Daniela Benz; Stephan Imfeld; Björn Jacobi; Pavel Broz; Kurt A Jäger; Martin Takes; Rolf W Huegli; Deniz Bilecen; Ulrich A Walker
Journal:  Arthritis Res Ther       Date:  2012-10-04       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.